Rinza tab. No. 10

Release form, composition and packaging

?

The tablets are round, flat, pink in color with dark pink and white blotches, with beveled edges and a dividing line on one side.

1 tab.

paracetamol 500 mg

caffeine 30 mg

phenylephrine hydrochloride 10 mg

chlorphenamine maleate 2 mg

colloidal silicon dioxide, corn starch, corn starch (for 20% paste), povidone (K30), sodium methyl parahydroxybenzoate, magnesium stearate, talc, sodium carboxymethyl starch (type A), crimson dye (Ponso 4R).

10 pieces.

- blisters (1) - cardboard packs.

pharmachologic effect

Combined drug.

Paracetamol has analgesic and antipyretic effects.

Reduces pain associated with colds - sore throat, headache, muscle and joint pain, reduces fever.

Phenylephrine is an alpha1-adrenergic agonist.

It has a vasoconstrictor effect, reduces edema and hyperemia of the mucous membranes of the upper respiratory tract and paranasal sinuses.

Chlorphenamine - a blocker of histamine H1-receptors, has an antiallergic effect, reduces swelling and hyperemia of the mucous membranes of the nasal cavity, nasopharynx and paranasal sinuses, eliminates itching in the eyes and nose, reduces exudative manifestations.

Caffeine has a stimulating effect on the central nervous system, which leads to a decrease in fatigue and drowsiness, and to an increase in mental and physical performance.

Pharmacokinetics

Data on the pharmacokinetics of Rinza® are not provided.

Indications for use

- symptomatic treatment of colds", acute respiratory viral infections (including influenza), accompanied by fever, pain syndrome, rhinorrhea.

Contraindications for use

- severe atherosclerosis of the coronary arteries - arterial hypertension (severe course) - diabetes mellitus (severe course) - Simultaneous intake of tricyclic antidepressants, MAO inhibitors, beta-blockers - simultaneous administration of drugs containing components of the Rinza® drug - pregnancy - lactation period - children up to age 15 - hypersensitivity to drug components. The drug should be used with caution in arterial hypertension, hyperthyroidism, pheochromocytoma, diabetes mellitus, bronchial asthma, chronic obstructive pulmonary disease, glucose-6-phosphate dehydrogenase deficiency, blood diseases, congenital hyperbilirubinemia (Gilbert's syndrome, Dubin-Johnson syndrome, Rotor syndrome), liver and / or renal failure, angle-closure glaucoma,hyperplasia of the prostate.

Dosage regimen

Adults and children over 15 years of age are prescribed 1 tab.

3-4 times / day

The maximum daily dose is 4 tab.

The course of treatment is no more than 5 days.

Overdose

Due, as a rule, to paracetamol, an overdose appears after taking more than 10-15 g of the latter.

Symptoms: pallor of the skin, anorexia, nausea, vomiting, hepatonecrosis, increased activity of hepatic transaminases, increased prothrombin time.

Treatment: gastric lavage followed by the appointment of activated carbon, symptomatic therapy, the introduction of methionine 8-9 hours after the overdose and acetylcysteine ​​- 12 hours later.

Side effect

Allergic reactions: skin rash, itching, urticaria, angioedema.

From the side of the central nervous system: dizziness, sleep disturbance, hyperexcitability.

From the side of the cardiovascular system: increased blood pressure, tachycardia.

From the digestive system: dry mouth, nausea, vomiting, epigastric pain, hepatotoxic effect.

From the side of the organ of vision: mydriasis, paresis of accommodation, increased intraocular pressure.

From the hematopoietic system: anemia, thrombocytopenia, agranulocytosis, hemolytic anemia, aplastic anemia, methemoglobinemia, pancytopenia.

From the urinary system: renal colic, glucosur

Dosage

paracetamol 500 mg, caffeine 30 mg, phenylephrine hydrochloride 10 mg, chlorphenamine maleate 2 mg.

Structure

1 tablet contains: Active ingredients: paracetamol 500 mg, caffeine 30 mg, phenylephrine hydrochloride 10 mg, chlorphenamine maleate 2 mg.

Excipients: Colloidal silicon dioxide, crimson dye 4R, corn starch, povidone (K-30), sodium methylhydroxybenzoate, magnesium stearate, purified talc, sodium starch glycolate, purified water.

Storage conditions and periods

In a dry, dark place at a temperature not exceeding 25 degrees.

INN / Active ingredient

chlorphenamine maleate, caffeine, paracetamol, phenylephrine hydrochloride

Specifications

Category

Pain and fever

Scope of the drug

General

Release form

Tablet

Manufacturer country

India

Package quantity, pcs

ten

Minimum age from

15 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Rinza

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Dosage form

Pills

Expiration date in days

1095

A type

Medicine

Package weight, g

twenty

Dosage (volume) of the substance in the preparation

:

paracetamol 500 mg, caffeine 30 mg, phenylephrine hydrochloride 10 mg, chlorphenamine maleate 2 mg.

Mode of application

:

Adults and children over 15 years of age are prescribed 1 tab.

3-4 times / day.

The maximum daily dose is 4 tab.

The course of treatment is no more than 5 days.

Pharmaco-therapeutic group

:

ARI and "cold" symptoms remedy (analgesic non-narcotic drug + psychostimulant + alpha-adrenergic agonist + H1-histamine receptor blocker)

Anatomical and therapeutic characteristics

:

N02BE71 Paracetamol, in combination with psychotropic drugs

Information on technical characteristics, delivery set, country of manufacture "